Well, after having my head handed to me by V.SSS a few years ago ...I swore I would never ride another FDA /  phase result on a junior biotech...I  will only buy and hold but always sell before the results are finally released.

In the one in a million chance it is a blockbuster ...I am willing to buy back in at a higher price.

Next on the radar....SDI...also in a phase III and will surely enjoy a ride up over the next months / year.

Good luck to whom ever looks at this stock...

As for NPC it is likely over....a reverse split is likely the only option to raise capital in the future. 1 for 10 or something like that...followed by the usual financings and the years (5-10) to see another set of trials from start to finish.

That junior biotechs for you.